Thyroid Hormone Use: Trends in the United States from 1960 Through 1988
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Thyroid hormone preparations comprised over 1% of all prescriptions filled by retail pharmacies during 1988 in the conterminous United States, i.e., the 48 contiguous states. Their large market share gives the patterns of their use substantial public health importance. This article describes prescription thyroid hormone use in the United States from 1960 through 1988, using pharmaceutical marketing research data collected from panels of retail pharmacies and office-based physicians. Although the use of natural products has declined by over 50% since 1960, about one fourth of all thyroid hormone prescriptions were for natural preparations as recently as 1988. Per capita thyroid mentions (i.e., patient-physician contacts during which a thyroid agent of any kind was recommended, prescribed, dispensed, administered, ordered to be given by a hospital, or given as a sample) doubled during this period among those over 59 years old. Per capita mentions for synthetic thyroid products increased fourfold and tenfold among men and women in this age group, respectively. Use for weight loss, despite the label's boxed warning indicating it to be ineffective and potentially dangerous, has diminished but persists. Obesity was second only to hypothyroidism among the diagnoses underlying thyroid product mentions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harington, C. R., & Barger, G. (1927) · Biochemical Journal · doi:10.1042/bj0210169 · Cited by 319
Surks, M. I., Schadlow, A. R., & Oppenheimer, J. H. (1972) · Journal of Clinical Investigation · doi:10.1172/jci107137 · Cited by 188
The Aging Thyroid: The Use of Thyroid Hormone in Older Persons
Sawin, C. T. (1989) · JAMA · doi:10.1001/jama.261.18.2653 · Cited by 94 · cited 2×
“This is consistent with a recent report of thyroid hormone use for obesity by 1% and for other unapproved indications by 15% of an unselected group of 178 thyroid users over 57 years old (12).”
Morbidity, Mortality, and Quality of Life for Patients Treated With Levothyroxine
Petersen, K. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.1990.00390210063015 · Cited by 69 · cited 1×
“For example, over 90% of the thyroid hormone prescriptions dispensed in Saskatchewan during the period 1980-1984 were for levothy¬ roxine (43), whereas in Sweden, levothyroxine is reportedly used virtually exclusively (53).”
Cited by
The history and future of treatment of hypothyroidism
McAninch, E. A., & Bianco, A. C. (2016) · Annals of Internal Medicine · doi:10.7326/m15-1799 · Cited by 118
Paradigm shifts in thyroid hormone replacement therapies for hypothyroidism
Wiersinga, W. M. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.258 · Cited by 114
Optimal thyroid hormone replacement
Jonklaas, J. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab031 · Cited by 89
Individualized Therapy for Hypothyroidism: Is T4 Enough for Everyone?
Ettleson, M. D., & Bianco, A. C. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa430 · Cited by 75
Millan-Alanis, J. M., González-González, J. G., Flores-Rodríguez, A., Singh Ospina, N., Maraka, S., Moreno-Peña, P. J., Brito, J. P., González-Velázquez, C., & Rodríguez-Gutiérrez, R. (2021) · Thyroid® · doi:10.1089/thy.2021.0270 · Cited by 60
Metadata
- Authors
- KAUFMAN, S. C., GROSS, T. P., & KENNEDY, D. L.
- Venue
- Thyroid
- Publisher
- SAGE Publications
- Published
- 1991-01
- Volume
- 1
- Issue
- 4
- Pages
- 285-291
- ISSN
- 1050-7256 (ISSN-L)
- 1557-9077
- OpenAlex
- W1998745607
- Cited by
- 45
- References
- 4
- FWCI
- 0.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Thyroid Hormone Use: Trends in the United States from 1960 Through 1988. https://app.cochat.ai/papers/10.1089/thy.1991.1.285
- The paper
- KAUFMAN, S. C., GROSS, T. P., & KENNEDY, D. L. (1991). Thyroid Hormone Use: Trends in the United States from 1960 Through 1988. Thyroid. https://doi.org/10.1089/thy.1991.1.285
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.